High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation

Barker, 2010, Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities., Biol Blood Marrow Transplant, 16, 1541, 10.1016/j.bbmt.2010.08.011 Scaradavou, 2013, Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia., Blood, 121, 752, 10.1182/blood-2012-08-449108 Brunstein, 2007, Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease., Blood, 110, 3064, 10.1182/blood-2007-04-067215 MacMillan, 2009, Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors., Blood, 113, 2410, 10.1182/blood-2008-07-163238 Ponce, 2013, Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match., Biol Blood Marrow Transplant, 19, 904, 10.1016/j.bbmt.2013.02.008 Brunstein, 2010, Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood., Blood, 116, 4693, 10.1182/blood-2010-05-285304 Ponce, 2011, Reduced late mortality risk contributes to similar survival after double-unit cord blood transplantation compared with related and unrelated donor hematopoietic stem cell transplantation., Biol Blood Marrow Transplant, 17, 1316, 10.1016/j.bbmt.2011.01.006 Paczesny, 2009, A biomarker panel for acute graft-versus-host disease., Blood, 113, 273, 10.1182/blood-2008-07-167098 Paczesny, 2010, Elafin is a biomarker of graft-versus-host disease of the skin., Sci Transl Med, 2, ra2, 10.1126/scitranslmed.3000406 Ferrara, 2011, Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease., Blood, 118, 6702, 10.1182/blood-2011-08-375006 Harris, 2012, Plasma biomarkers of lower gastrointestinal and liver acute GVHD., Blood, 119, 2960, 10.1182/blood-2011-10-387357 Levine, 2012, Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study., Blood, 119, 3854, 10.1182/blood-2012-01-403063 Vander Lugt, 2013, ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death., N Engl J Med, 369, 529, 10.1056/NEJMoa1213299 Alsultan, 2011, GVHD after unrelated cord blood transplant in children: characteristics, severity, risk factors and influence on outcome., Bone Marrow Transplant, 46, 668, 10.1038/bmt.2010.174 Snover, 1985, Mucosal damage simulating acute graft-versus-host reaction in cytomegalovirus colitis., Transplantation, 39, 669, 10.1097/00007890-198506000-00019 Bombí, 1995, Assessment of histopathologic changes in the colonic biopsy in acute graft-versus-host disease., Am J Clin Pathol, 103, 690, 10.1093/ajcp/103.6.690 Ponec, 1999, Endoscopic and histologic diagnosis of intestinal graft-versus-host disease after marrow transplantation., Gastrointest Endosc, 49, 612, 10.1016/S0016-5107(99)70390-1 Liakopoulou, 2005, Rotavirus as a significant cause of prolonged diarrhoeal illness and morbidity following allogeneic bone marrow transplantation., Bone Marrow Transplant, 36, 691, 10.1038/sj.bmt.1705127 Selbst, 2009, Spectrum of histologic changes in colonic biopsies in patients treated with mycophenolate mofetil., Mod Pathol, 22, 737, 10.1038/modpathol.2009.44 Alonso, 2012, Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients., Clin Infect Dis, 54, 1053, 10.1093/cid/cir1035 Barker, 2011, How I treat: the selection and acquisition of unrelated cord blood grafts., Blood, 117, 2332, 10.1182/blood-2010-04-280966 Barker, 2009, A “no-wash” albumin-dextran dilution strategy for cord blood unit thaw: high rate of engraftment and a low incidence of serious infusion reactions., Biol Blood Marrow Transplant, 15, 1596, 10.1016/j.bbmt.2009.08.009 Rowlings, 1997, IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade., Br J Haematol, 97, 855, 10.1046/j.1365-2141.1997.1112925.x Filipovich, 2005, National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report., Biol Blood Marrow Transplant, 11, 945, 10.1016/j.bbmt.2005.09.004 Copelan, 2007, A scheme for defining cause of death and its application in the T cell depletion trial., Biol Blood Marrow Transplant, 13, 1469, 10.1016/j.bbmt.2007.08.047 Saha, 2010, Time-dependent predictive accuracy in the presence of competing risks., Biometrics, 66, 999, 10.1111/j.1541-0420.2009.01375.x Gonen, 2005, Concordance probability and discriminatory power in proportional hazards regression., Biometrika, 92, 965, 10.1093/biomet/92.4.965 Eapen, 2011, Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis., Lancet Oncol, 12, 1214, 10.1016/S1470-2045(11)70260-1 Dahi, 2014, Donor-recipient allele-level HLA matching of unrelated cord blood units reveals high degrees of mismatch and alters graft selection., Bone Marrow Transplant, 49, 1184, 10.1038/bmt.2014.135 Soiffer, 2011, Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies., Blood, 117, 6963, 10.1182/blood-2011-01-332007 Brunstein, 2006, Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation., Blood, 108, 2874, 10.1182/blood-2006-03-011791 Chen, 2012, Reduced-intensity conditioning stem cell transplantation: comparison of double umbilical cord blood and unrelated donor grafts., Biol Blood Marrow Transplant, 18, 805, 10.1016/j.bbmt.2011.10.016 Sanz, 2014, EBV-associated post-transplant lymphoproliferative disorder after umbilical cord blood transplantation in adults with hematological diseases., Bone Marrow Transplant, 49, 397, 10.1038/bmt.2013.190 Lindemans, 2014, Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome., Blood, 123, 126, 10.1182/blood-2013-05-502385 Dinarello, 2011, Interleukin-1 in the pathogenesis and treatment of inflammatory diseases., Blood, 117, 3720, 10.1182/blood-2010-07-273417 Schmitz, 2005, IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines., Immunity, 23, 479, 10.1016/j.immuni.2005.09.015 Garlanda, 2013, The interleukin-1 family: back to the future., Immunity, 39, 1003, 10.1016/j.immuni.2013.11.010 Barker, 2010, Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies., Blood, 115, 1843, 10.1182/blood-2009-07-231068 Eapen, 2014, Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy., Blood, 123, 133, 10.1182/blood-2013-05-506253 Malard, 2010, Impact of cyclosporine-A concentration on the incidence of severe acute graft-versus-host disease after allogeneic stem cell transplantation., Biol Blood Marrow Transplant, 16, 28, 10.1016/j.bbmt.2009.08.010 Mori, 2012, Effect of early posttransplantation tacrolimus concentration on the development of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation from unrelated donors., Biol Blood Marrow Transplant, 18, 229, 10.1016/j.bbmt.2011.06.008 Ram, 2012, Association between calcineurin inhibitor blood concentrations and outcomes after allogeneic hematopoietic cell transplantation., Biol Blood Marrow Transplant, 18, 414, 10.1016/j.bbmt.2011.08.016 Rogosheske, 2014, Higher therapeutic CsA levels early post transplantation reduce risk of acute GVHD and improves survival., Bone Marrow Transplant, 49, 122, 10.1038/bmt.2013.139 Jacobson, 2010, Mycophenolate pharmacokinetics and association with response to acute graft-versus-host disease treatment from the Blood and Marrow Transplant Clinical Trials Network., Biol Blood Marrow Transplant, 16, 421, 10.1016/j.bbmt.2009.11.010 Harnicar, 2014, Higher mycophenolic acid (MPA) trough levels result in lower day 100 severe acute graft-versus-disease disease (aGVHD) without increased toxicity in double-unit cord blood transplantation (CBT) recipients., Biol Blood Marrow Transplant, 20, S52, 10.1016/j.bbmt.2013.12.054 Jenq, 2012, Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation., J Exp Med, 209, 903, 10.1084/jem.20112408 Hanash, 2012, Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease., Immunity, 37, 339, 10.1016/j.immuni.2012.05.028 Cooke, 1996, An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin., Blood, 88, 3230, 10.1182/blood.V88.8.3230.bloodjournal8883230